Submitted by Anonymous (not verified) on 12 November 2024 - 16:13
Human medicines European public assessment report (EPAR): Alecensa, alectinib, Date of authorisation: 16/02/2017, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Alecensa, alectinib, Date of authorisation: 16/02/2017, Revision: 16, Status: Authorised